Table 3.
Not-treated (n = 21) | Treated (n = 20) | Statistical analyses | |
---|---|---|---|
p Value | |||
Q1 (L eo/L ec) | 0.48 ± 0.10 | 0.58 ± 0.14 | 0.001 |
Q2 (L eof/L ecf) | 0.47 ± 0.12 | 0.59 ± 0.11 | 0.001 |
Q3 (L eo/L ecf) | 0.36 ± 0.11 | 0.46 ± 0.12 | 0.001 |
Not-treated (n = 21) | Treated (n = 20) | Statistical analyses | |
---|---|---|---|
p Value | |||
Q1 (L eo/L ec) | 0.48 ± 0.10 | 0.58 ± 0.14 | 0.001 |
Q2 (L eof/L ecf) | 0.47 ± 0.12 | 0.59 ± 0.11 | 0.001 |
Q3 (L eo/L ecf) | 0.36 ± 0.11 | 0.46 ± 0.12 | 0.001 |